{"text": ["The price of priority review: $67.5 million"], "created_at": "Thu, 09 Oct 2014 07:00:00 GMT"}
{"text": ["First PI3k inhibitor launches into crowded hematology markets"], "created_at": "Thu, 09 Oct 2014 07:00:00 GMT"}
